As if the Delta and Omicron variants of coronavirus were n’t formerly enough, a professor of natural lores in Cyprus has now claimed that a new strain of SARS-CoV-2 that combines features of Delta and Omicron has been plant in his country.
Leondios Kostrikis, professor at the University of Cyprus and head of the Laboratory of Biotechnology and Molecular Virology, has been quoted in media reports as saying, “ There are presently Omicron and Deltaco-infections and we plant this strain that’s a combination of these two. The discovery was named Deltacron due to the identification of Omicron-suchlike inheritable autographs within the Delta genome.”
25 CASES FOUND?
As per reports, Leondios Kostrikis and his platoon have, so far, linked 25 cases of‘Deltacron’in Cyprus The experimenters transferred their findings to GISAID, the transnational database that tracks contagions, on January 7. It’s important to note that‘Deltacron’has not been recognised or designated by any transnational health authority as of now.
‘NOT EVERY MUTATION IS ALARMING’
It’s too early to say what impact, if any,‘Deltacron’could have on the global fight against Covid-19. But according to its adventurer Leondios Kostrikis, the new strain is likely to be “ displaced by the largely contagious Omicron variant”, reports said Some virologists have said‘Deltacron’isn’t a new variant because it can not be traced or colluded on a phylogenetic tree of SARS-CoV-2 contagions. Virologist Tom Peacock said on social media, “ Small update the Cypriot’Deltacron’ sequences reported by several large media outlets look to be relatively easily impurity-they don’t cluster on a phylogenetic tree and have a whole Artic manual sequencing amplicon of Omicron in an else Delta backbone” (sic). Sunit K Singh, virologist and professor at Institute of Medical Lores at Banaras Hindu University, said, “ It’s in the nature of an RNA contagion similar as SARS-CoV-2, especially of a respiratory nature, to mutate. While we may find numerous mutations, its recombinant forms need to be reused. In public health, not every mutation is intimidating.”
